Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

21
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
21
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

18
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
18
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

38
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
38
Nephrons01:10

Nephrons

3.3K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.3K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

59
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
59
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

70
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
70

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serine protease HTRA1 is a common autoantigen in membranous nephropathy in patients of 80 years and older.

Kidney international·2026
Same author

[Primary glomerulonephritides].

Innere Medizin (Heidelberg, Germany)·2026
Same author

Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragment.

The EMBO journal·2025
Same author

Spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney disease.

Nature immunology·2025
Same author

The authors reply.

Kidney international·2025
Same author

Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma.

Leukemia·2025

Related Experiment Video

Updated: Aug 30, 2025

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.5K

[Update nephrotic syndrome - new pathophysiologic concepts 2022].

Elion Hoxha1

  • 1III. Medizinische Klinik und Poliklinik, Universitätsklinikum Hamburg-Eppendorf.

Deutsche Medizinische Wochenschrift (1946)
|August 28, 2022
PubMed
Summary
This summary is machine-generated.

Autoantibodies targeting specific antigens like PLA2R1 are key in membranous nephropathy (MN) diagnosis and treatment. Further research is needed to clarify immune response triggers and roles of novel antigens in MN, MCD, and FSGS.

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.0K
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.4K

Related Experiment Videos

Last Updated: Aug 30, 2025

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.5K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.0K
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.4K

Area of Science:

  • Nephrology
  • Immunology
  • Pathogenesis of Kidney Diseases

Background:

  • Autoantibodies are identified as key drivers in membranous nephropathy (MN) development.
  • Antigen-specific diagnosis and treatment strategies are emerging for MN.
  • The precise mechanisms initiating immune responses against antigens like PLA2R1 remain unclear, with potential environmental and genetic influences.

Purpose of the Study:

  • To highlight the importance of antigen-specific diagnosis in developing individualized management strategies for MN patients.
  • To emphasize the need for further research into the pathogenetic roles of PLA2R1, THSD7A, and other novel antigens in MN.
  • To discuss the current understanding and evolving concepts of T-cell and B-cell involvement in Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS).

Main Methods:

  • Review and synthesis of current literature on autoantibodies in nephropathy.
  • Analysis of diagnostic and therapeutic implications of antigen-specific approaches.
  • Discussion of pathogenetic mechanisms in MN, MCD, and FSGS.

Main Results:

  • Identification of autoantibodies has enabled antigen-specific diagnosis and treatment for MN.
  • THSD7A-expressing tumors are implicated in THSD7A-induced MN.
  • Novel target antigens in MN are continually being described, requiring further pathogenetic definition.

Conclusions:

  • Antigen-specific diagnosis is crucial for personalized MN management, including risk assessment and treatment adjustment.
  • Understanding the role of domain-specific PLA2R1 antibodies and novel antigens is essential.
  • While T-cell disruption is hypothesized in MCD/FSGS, B-cell and autoantibody roles are increasingly considered, with steroids remaining first-line therapy.